Aryl hydrocarbon receptor (AhR), or dioxin receptor, is a transcription factor that induces adaptive metabolic pathways in response to environmental pollutants. Recently, other pathways were found to be altered by AhR and its ligands. Indeed, developmental defects elicited by AhR ligands suggest that additional cellular functions may be targeted by this receptor, including cell migration and plasticity. Here, we show that dioxin-mediated activation of Ahr induces Nedd9/Hef1/Cas-L, a member of the Cas protein family recently identified as a metastasis marker. The Hef1 gene induction is mediated by two xenobiotic responsive elements present in this gene promoter. Moreover, using RNA interference, we show that Nedd9/Hef1/Cas-L mediates the dioxin-elicited changes related to cell plasticity, including alterations of cellular adhesion and shape, cytoskeleton reorganization, and increased cell migration. Furthermore, we show that both E-cadherin repression and Jun N-terminal kinases activation by dioxin and AhR also depend on the expression of Nedd9/Hef1/Cas-L. Our study unveils, for the first time, a link between pollutants exposure and the induced expression of a metastasis marker and shows that cellular migration and plasticity markers are regulated by AhR and its toxic ligands.
Introduction
Environmental pollutants such as dioxins, PCBs and polyaromatic hydrocarbons exert a variety of long-term toxic effects in animals and humans, including alterations in fetal development, immunotoxicity and cancer. The actual mechanisms of these effects remain elusive. A large number of these pollutants are potent ligands and activators of aryl hydrocarbon receptor (AhR), which is required for their toxic effects as revealed by AhR knockout mice. One of the main functions of this receptor is the well-described adaptative regulation of xenobiotic metabolism (Kohle and Bock, 2007) . Indeed, on ligand binding, AhR forms a transcription factor with its partner ARNT and induces a number of xenobiotic metabolizing enzymes, such as those of the cytochromes P450 1 family (CYP1). However, this function accounts for only part of the toxicity of AhR ligands, as shown by targeted knockouts of some of the CYP genes. Thus, alternative mechanisms have been investigated (Mulero-Navarro et al., 2005; Diry et al., 2006) . The activation of this receptor has been shown to elicit diverse cellular alterations, including modifications of cell cycle regulation, cell migration and contact inhibition (Mulero-Navarro et al., 2005; Puga et al., 2005; Diry et al., 2006) . These alterations could possibly mediate part of the long-term toxicities of the AhR ligands in animals and humans; chronic exposure to several AhR ligands, which are common and persistent pollutants, is frequent in industrialized populations (tobacco smoke, air pollution, food contamination). However, the primary target gene(s) that could mediate such effects remain elusive.
Few studies have addressed the possibility that environmental pollutants could target cellular plasticity, a set of phenotypic changes in cell adhesion, cytoskeleton reorganization and migratory behavior correlated with modulation of gene expression. We have investigated the possible implication of AhR in those events as any dysregulation of these cellular pathways may disrupt normal fetal development and favor cancer progression in addition to a variety of other toxic effects. We have particularly focused on regulatory proteins that control cellular migration; indeed, preliminary large-scale studies indicated that the Nedd9/ Hef1/Cas-L gene (named Hef1 in the rest of the article) might be modulated by dioxin in human cultured cells (Frueh et al., 2001; Diry et al., 2006) .
Hef1 has been identified as a filamentation inducer in a human cDNA screen in Saccharomyces cerevisae (Law et al., 1996) . As a scaffold protein, it mediates integrin signaling, relaying transduction signals notably toward Jun N-terminal kinases (JNKs) and apoptosis pathways (Law et al., 2000) . Recently, Hef1 has been linked to the regulation of the mitotic spindle and primary cilium formation (Pugacheva and Golemis, 2005; Pugacheva et al., 2007) ; interestingly, screening for metastasis markers in cancer samples has identified Hef1 as a frequent tag in melanoma progressing tumors (Kim et al., 2006; Ji et al., 2007) . Considering the lack of studies on the potential implications of environmental pollutants in cancer progression and in the regulation of cellular plasticity, we believed that a link between the AhR and Hef1 expression would be of primary importance. The aim of this study was to decipher the induction mechanism of Hef1 by dioxin and its receptor in the HepG2 cells and then to unravel the contribution of this new AhR target to the cellular events elicited by environmental pollutants.
Results
HepG2 cells were routinely treated with 25 nM dioxin, which is in line with the concentration range used to treat human cells (5-100 nM). Figure 1 (and see Supplementary information SF1) shows several independent fields of control and dioxin-treated HepG2 cells; dioxin (TCDD, tetrachlorodibenzo-p-dioxin) elicits a time-dependent cells desegregation, which starts at 24 h of treatment and which is clearly observed after 48 h. The treated cells adopt a crescent-like shape and have lost the contacts present in control cells ( Figure 1a) . A dose-response experiment confirms that the modification of cell shape by dioxin starts at 1 nM, is clear at 10 nM and maximal at 25 nM, which is consistent with the known affinity of AhR for this pollutant in humans (data not shown). We next examined the cytoskeleton reorganization by using immunofluorescent actin and vinculin staining to confirm those preliminary observations. Vinculin is known to interact with integrins, to modulate focal adhesion structure and functions, and to have key roles in cell shape control; it is critical for the control of cell spreading and lamellipodia formation (Ziegler et al., 2006) . A dramatic increase of the vinculin-containing focal adhesion sites number and lamellipodia was observed in dioxin-treated cells together with cell shape changes ( Figure 1b) . As dioxin exerts most, if not all, of its effects through AhR activation, we assessed the contribution of this receptor by carrying AhR small interfering RNA (siRNA) knockdown experiments in HepG2 cells (Figures 1c and d) . Although dioxin still modified cell shape and cytoskeleton organization in control siRNA-transfected cells, knockdown of AhR (see siRNA effects on Figure 2d , and see Supplementary information SF2) dramatically reduced the number of crescent-shaped cells ( Figure 1c ) and focal adhesion sites number (Figure 1d ) on dioxin treatment. This confirms that dioxin and its receptor trigger cellular plasticity and alter cellular morphology in HepG2 cells.
To identify putative AhR targets involved in these cellular events, we screened several microarray data (from our laboratory and from other groups) to monitor gene expression changes on dioxin treatment of HepG2 cells (Ma and Whitlock, 1996; Frueh et al., 2001; Marchand et al., 2005) and noted that the Nedd9/Hef1/ Cas-L appeared to be a putative target. As recent data indicated that this gene could be involved in cellular plasticity and tumor metastasis, it was important to first confirm and characterize the modulation of Hef1 by dioxin and by AhR in HepG2 cells. Figure 2 shows that dioxin significantly increases Hef1 mRNA and protein expression (Figures 2a and b) in a dose-dependent and time-dependent manner. Maximal increase was achieved at 24-h treatment time and at 10 nM (Figures 2a and b) . This confirms that dioxin induces Hef1 expression in HepG2 cells. To assess the tissue specificity of Hef1 induction by dioxin in an in vivo context, we measured Hef1 mRNA levels in several mice tissues on TCDD treatment; we found that Hef1 mRNA is significantly induced in the skin, heart, skeletal muscle and liver on TCDD exposure (data not shown).
Our next goal was to decipher the mechanism of dioxin-dependant Hef1 induction. We used 5,6-dichloro-beta-D ribofuranosyl benzimidazole to block mRNA synthesis and assess Hef1 mRNA half-life. Figure 3a shows that Hef1 mRNA half-life, measured by quantitative real-time PCR (RT-PCR), was similar in control and dioxin-treated cells, suggesting that this xenobiotic induces Hef1 at the transcriptional level. The contribution of AhR to this regulation was assessed using two different approaches; first, we treated the MDA-MB-231 mammary cells, which do not express AhR, with dioxin (see Supplementary information SF3). We did not observe Hef1 mRNA induction as observed with AhR-expressing HepG2 and MCF-7 cells (Diry et al., 2006) . Next, we performed AhR mRNA knockdown with our validated siRNAs (Qiagen, Courtaboeuf, France) (see also Figures 1c and d) . A significant reduction of AhR mRNA levels (40-60%) leads to a similar decrease in Hef1 and Cyp1A1 mRNA-induced levels ( Figure 3b ; and see Supplementary information SF2). Cytochrome P450 1A1 (Cyp1A1) is one of the most sensitive and classical markers of AhR activation. Interestingly, under untreated conditions, Hef1 mRNA levels were not affected by AhR siRNA transfection (Figure 3b ). Finally, we analysed Hef1 human promoter using both in silico and in vitro approaches. Promoter sequence analysis reveals the presence of two putative consensus dioxin or xenobiotic responsive elements (XREs) in positions À780 and À648 (XRE1 and XRE2, respectively) ( Figure 3c ). We sub-cloned the À850/ þ 4 Hef1 promoter fragment in a firefly luciferase reporter vector (pGL3 basic vector from Promega, Madison, WI, USA). Transfection experiments showed that the Hef1 promoter displayed a four fold activation by dioxin (Figure 3d ). We also observed a significant 1.7-fold activation in MDA-MB-231 cells on transfection with both AhR and ARNT-expressing vectors (but not with one of them alone) (See Supplementary information in SF3B). To confirm our hypothesis, we carried out chromatin immunoprecipitation experiments to assay AhR promoter binding. Figure 3e (and Supplementary information SF4 for the quantitative data and a similar experiment on the CYP1A1 promoter for a positive control) shows that after a 15 or 45 min treatment, dioxin significantly stimulated AhR recruitment to the region encompassing both XREs. Finally, we tested several AhR ligands on Hef1 mRNA induction and discovered that benzo(a)pyrene, quercetin and 3-methylcholanthrene induced Hef1 mRNA expression ( Figure 3f ). In conclusion, those experiments show that Hef1 is a transcriptional target of AhR.
Next, we investigated the role of this metastatic marker in the cellular changes associated with dioxinexposed HepG2 cells by knockdown experiments using two targeted siRNA (named 143 and 528); we were able to downregulate dioxin-induced Hef1 expression with either siRNA (Figure 4a ). However, knockdown using siRNA 528 was more potent particularly in dioxin treated cells; indeed, siRNA 528 efficiently lowers Hef1 protein expression by >50% (Figure 4b ). Interestingly, on dioxin treatment, we observed a decrease in the number of cells harboring crescent-like structures in the presence of siRNA 528 ( Figure 4c ) and a dramatic reduction of focal adhesion sites ( Figure 4d ). Thus, the downregulation of Hef1 impairs the effects of dioxin on cell shape and cytoskeleton organization.
We next studied other dioxin-induced cellular and molecular events related to epithelial-mesenchymal transition and investigated the role of Hef1 by RNA interference. First, we measured the expression level of the classical epithelial marker, E-cadherin in our system. E-cadherin allows the formation of adherens junctions in tissues and epithelial sheets. A decrease of this marker is a hallmark of EMT (Thiery and Sleeman, 2006) ; in parallel, we also measured the activity of the stress kinases, JNK, which are classically phosphorylated by stress stimuli, loss of cell polarity and cell migration inducers (Huang et al., 2004) . We detected membrane expression of E-cadherin in HepG2 cells (Figure 5a , left panel). Interestingly, the staining sharply decreased on dioxin treatment (Figure 5a , right panel). We then monitored E-cadherin mRNA and protein levels in time-course experiments and, again, we were able to observe, for both samples, a dramatic decrease (o40% of the initial levels) after a 48-h treatment (Figure 5b ). Earlier time points did not show any changes in E-cadherin expression. In parallel, we observed an increase of JNK phosphorylation after a 24-h dioxin treatment ( Figure 5b ). Next, we investigated the effect of AhR and Hef1 siRNA on E-cadherin expression and JNK activation. Knockdown of AhR (see Supplementary information SF5) partially restores (82% of control levels) E-cadherin mRNA expression on dioxin treatment (Figure 5c ). Interestingly, Hef1 siRNA 528 exerts the same effect ( Figure 5d ). As loss of E-cadherin expression is one condition that favors migration of epithelial cells, we tested the effect of dioxin and the contribution of Hef1 induction on HepG2 migration. We show that dioxin elicits a twofold increase in cell migration speed in wound healing assays ( Figure 6a) ; this effect of dioxin was largely blunted in Hef1 siRNA 528-treated cells (Figure 6a ). Under these conditions, migration speed was close to that of the control untreated cells. Consistent with our previous observations, siRNA 528 had no effect on the basal migration speed level. The activation of cell migration by dioxin was confirmed using an additional assay, the Boyden chamber invasion assay (Figure 6b ). Thus, in addition to its effect on cell shape and cytoskelton organization, Hef1 seems to be critical for dioxin-mediated effects on cell migration, E-cadherin expression and JNK activation.
Discussion
The link that we describe here between AhR activation, Hef1 induction and cell plasticity may constitute a novel mechanism of pollutants toxicity, notably during development and cancer progression. Historically, AhR activation has been linked to induced expression of phase I and phase II xenobiotic enzymes, which facilitate pollutants and drugs clearance from metazoan organisms. However, recent studies have unveiled the regulation of new target genes (Frueh et al., 2001; Diry et al., 2006) . Our experiments now establish Hef1 as an important member of this 'new' AhR target gene family, as was initially suggested by Frueh et al. (2001) . Our initial observations of HepG2 morphological changes on dioxin treatment led us to search for dioxinupregulated targets, which were putatively involved in the regulation of cell attachment, adhesion and migration. This study validates Hef1 as an AhR target for the first time.
There is now a clear connection between Hef1 expression and cancer progression both from clinical and experimental studies (Kim et al., 2006; Ji et al., 2007) . Indeed, overexpression of this gene has been implicated in the regulation of cell migration (O'Neill and Golemis, 2001; Natarajan et al., 2006; Regelmann et al., 2006) , which might explain its potential role in cancer progression (Kim et al., 2006; Ji et al., 2007) . Several cellular pathways involving Hef1 have been described in the past few years that could explain this phenomenon. First, Hef1 acts as a scaffold protein for integrin signaling, which regulates cell anchorage and migration (Seo et al., 2006) . Moreover, its 'organizing' role on primary cilium and mitotic spindle formation could also be related to cell differentiation and consequently, cancer development (Pugacheva and Golemis, 2005; Pugacheva et al., 2007) . Hef1 expression levels seem to be critical in order to allow proper function of those different cell structures. Indeed, depletion of Hef1 by RNA interference leads to abnormal centrosome formation, whereas its overexpression induces supernumerary centrosomes and multipolar mitotic spindles Golemis, 2005, 2006) . Thus, the observed regulation of Hef1 by AhR may be relevant to account for developmental and migration-related toxicities of environmental pollutants. These observations open the possibilities that pollutants could trigger cancer cell migration and suggest that further studies will be needed to decipher a potential action of xenobiotics in the regulation of metastatic progression.
Chronic exposure to AhR ligands is very common, especially in industrialized countries. Moreover, dioxins tend to accumulate in adipose and hepatic tissues because of their low chemical reactivity and high hydrophobicity; their long half-life (7-8 years) in humans might be responsible of long-term effects even after acute contamination. Hef1 upregulation by AhR ligands might not be critical for the first steps of cancer development, such as initiation and promotion. However, considering the clinical observations revealing Hef1 as a marker of metastatic cells, we hypothesize that its induction by pollutants in primary tumors might favor cancer progression. Thus, in addition to their effects on tumor initiation and promotion, some xenobiotics could trigger cellular conditions that favor tumor progression, as suggested here for AhR ligands. In addition, humans and animals are chronically exposed to complex mixtures of pollutants, rather than to a single one. Some of these pollutants are known to act as tumor initiators and/or tumor promoters, but one can speculate that some xenobiotics may act as tumor 'progressors', possibly in combination with genetic, inflammatory or nutritional conditions. Although a variety of endogenous hormones or signaling factors have been suspected to favor metastasis (Aguirre-Ghiso, 2007), little is known in this field on the effects of pollutants. Three independent studies examined cytochrome P450 profile expression in different metastatic tumors and found a significant upregulation of some AhR-target members, including CYP1B1, CYP2S1 and aromatase CYP19 (Downie et al., 2005; Kumarakulasingham et al., 2005; Haas et al., 2006) , which is in line with our hypothesis. However, the mechanisms of these upregulations remain elusive particularly because other cytochrome P450 genes are also increased. These observations indicate that additional studies in human populations exposed to high levels of pollutants are required and should attempt to correlate such exposure with tumor aggressiveness and metastasis.
The cellular effects of dioxin that we describe here have been observed in the context of a cancerous human cell line. It is unclear at this stage whether dioxin and the human AhR would activate in vivo cell migration under any physiological or pathological conditions. In this regard, it is interesting to note that the invertebrate Ahr, specifically in Caenorhabditis elegans and Drosophila, does not seem to mediate response to xenobiotics but is rather at least partially implicated in determining neuronal fate and migration, which is in line with our observations (Crews and Brenman, 2006; Qin et al., 2006; Wernet et al., 2006; McMillan and Bradfield, 2007) . Studies of rodent AhR lead to a more balanced view of its functions (McMillan and Bradfield, 2007) . Indeed, although AhR knockout mice exhibit developmental defects, these defects are not evidently due to a lack of epithelial to mesenchymal transition. In fact, it has been reported that one of the classical plasticity markers, transforming growth factor-b, is actually downregulated by dioxin and AhR activation in experimental setups in rodents (Puga et al., 2005) . At this stage, in analogy with the endocrine disrupting concept of environmental pollutants, we speculate that dioxin activation of AhR might lead to a disruption of endogenous AhR signaling and that dioxin-activated AhR acts essentially as a cellular transition modulator, favoring cell migration and EMT as we have shown in this study, but also altering some plasticity-related developmental processes in other contexts.
Materials and methods

Cell culture
Human hepatoblastoma HepG2 and mammary MDA-MB-231 cells were cultured at 37 1C in Dulbecco's minimal essential medium (DMEM) complemented with nonessential amino acids, supplemented with 10% fetal bovine serum, 200 U/ml penicillin, 50 mg/ml streptomycin (Invitrogen, Cergy-Pontoise, France) and 0.5 mg/ml amphotericin B (Bristol-Myers Squibb Co., Stamford, CT, USA) in a humidified atmosphere in 5% CO 2 . One day before treatment with various concentrations of TCDD, cells were cultivated in DMEM without phenol red supplemented with 3% charcoal-treated (desteroized) calf serum and maintained in this medium during all treatments. TCDD was purchased from LCG Promochem (Molsheim, France). Benzo(a)pyrene, 3-methylcholanthrene and quercetin were purchased from Sigma-Aldrich (St Louis, MO, US). Photographs were taken with an inverted microscope (Nikon TMS-F, 301655, Nikon FRANCE SAS, Champigny sur Marne, France) equipped with a digital camera (Nikon Digital shot DS-L1).
HEF1 mRNA half-life measurement On day 1, HepG2 cells were seeded at 400 000 cells per well (in 6-well plates) in complete DMEM medium (see above). On day 2, cells were washed with phosphate-buffered saline (PBS) and medium was changed for red phenol-free DMEM supplemented with 3% desteroidized fetal bovine serum, 200 U/ml penicillin, 50 mg/ml streptomycin and 0.5 mg/ml amphotericin B. Cells were treated with 25 nM TCDD. Twenty-four hours later (on day 3), cells were treated with 100 mM 5,6-dichlorobeta-D ribofuranosyl benzimidazole (Sigma-Aldrich) and lysates were recovered for each mentioned time points (2, 4, 6 and 10 h) using the RNeasy mini kit (Qiagen) (see also below). Quantitative RT-PCR was then carried out (see also below).
siRNA transfection
One day before transfection, HepG2 cells (4 Â 10 5 cells per well) were seeded in 6-well plates. Twenty-four hours later, the medium was replaced by DMEM without phenol red supplemented with 3% charcoal-treated (desteroized) calf serum and cells were then transfected with 5 nM siRNA, using the HiPerfect transfection reagent (Qiagen) according to the manufacturer's protocol. For Hef1 experiments, after 8 h of incubation at 37 1C, medium was replaced and cells were treated or not with 25 nM TCDD. Seventy-two hours after transfection, RNA and protein purification or cell immunofluorescence were carried out. For AhR experiments, cells were treated with 25 nM TCDD 16 h after transfection and extraction or immunostaining were performed 48 h after transfection. siRNA references and/or sequences (Qiagen) are: 
Reporter assays
The À850/ þ 4 human Hef1 promoter (NM_182966.2) was amplified by PCR and ligated in the polylinker sequence of pGL3 basic vector (Promega). Transfection experiments were carried out as follows: cells were seeded on 6-well plates (3 Â 10 5 cells per well), then 24 h later, the medium was replaced with DMEM without phenol red supplemented with 3% charcoal-treated calf serum and transfection experiments were carried out with lipofectamine (Invitrogen) according to the manufacturer's instructions. pCT131 empty vector was used as sequence control and pglob-Renilla luciferase as transfection control. Cells were treated 24 h after transfection with 25 nM dioxin. After an overnight incubation, cells were homogenized for enzymatic assays with phosphate lysis buffer (Promega). A dual luciferase assay (firefly and Renilla) was carried out with a Promega kit and a luminometer. The RL assay was used to normalize the transfection efficiency in all culture dishes. Blanks were obtained by assaying luciferase activity in mock-transfected cells. For the MDA-MB-231 experiments, we used similar transfection conditions with, in addition to the HEF1 promoter construct, 100 ng of empty, human AhR-or human ARNT-expressing vectors per well (a generous gift of Dr J-F Savouret, INSERM UMR-S 747, France).
Chromatin immunoprecipitation
The detailed protocol is provided as a Supplementary Information (SI-1).
Wound-healing assay HepG2 cells (1 Â 10 6 cells per well) were seeded on 6-well plates. Twenty-four hours later, the cells were cultivated in DMEM without phenol red supplemented with 3% charcoaltreated calf serum overnight and transfected with siHef1 528 or control as previously described. Six hours later, cells were treated with 25 nM dioxin. Twenty-four hours after transfection, HepG2 were wounded in serum-free medium, 1% bovine serum albumin (BSA) with a sterile 200 ml pipette tip to remove cells. After washing away suspended cells, treatment with 25 nM TCDD was continued. The progress of migration was photographed (after identification of each wounded zone) in six regions, immediately and during 2 days after wounding (0 h-24 h-48 h), using an inverted microscope (Nikon TMS-F, 301655) equipped with a digital camera (Nikon Digital shot DS-L1).
RNA extraction, reverse transcription and quantitative RT-PCR Total RNAs were extracted using the RNeasy mini kit (Qiagen) as described by the manufacturer and quantified with a spectrophotometer (ND-1000 Nanodrop, NanoDrop products, Wilmington, DE, USA). Reverse transcription was carried out on each RNA sample (2 mg) using the cDNA High-Capacity Archive kit from Applied Biosystems (Courtaboeuf, France) in a final reaction volume of 50 ml according to the manufacturer's instructions. All specific oligonucleotides were designed using the OLIGO Explorer software (Molecular Biology Insights, Inc, Cascade, CO, USA Oligonucleotides were obtained from Qiagen (Les Ulis, France). Quantitative RT-PCR was carried out with 40 ng of the cDNA, 300 nM of each primer and ABsolute QPCR SYBR Green (Abgene, Villebon sur Yvette, France) to a final volume of 10 ml. Quantitative RT-PCR measurements were carried out on an ABI PRISM 7900HT Sequence Detection System (Applied Biosystems). PCR cycles were proceeded as follows: Taq activation (15 min), denaturation (15 s, 95 1C), and annealing and extension (1 min, 60 1C). The melting-curve analysis showed the specificity of the amplifications. Threshold cycle, which inversely correlates with the target mRNA level, was measured as the cycle number at which the reporter fluorescent emission appears above the background threshold. The relative mRNA levels were estimated using the delta-delta method with RPL13A as reference gene. The PCR primer, RPL13A, was designed using Oligo Explorer software and its quantitative reverse transcription-PCR was carried out with Absolute quantitative PCR SYBR Green.
Immunoblotting Whole-cell lysates were prepared from HepG2 cells in M-PER mammalian protein extraction reagent containing protease and phosphatase inhibitor cocktail (Sigma). Equal amounts of total protein were separated by SDS-polyacrylamide gel electrophoresis and transferred onto nitrocellulose membranes. Blots were probed with primary antibodies that recognize HEF-1 (ImmuQuest, IQ297, 1:5000, North Yorkshire,UK), E-cadherin (Cell Signaling, 4065, 1:1000, Danvers, MA, USA), phosho-SAPK/JNK (Cell Signaling, 9251, 1:1000), SAPK/JNK (Cell Signaling, 9252, 1:1000) and actin (Abcam, ab37063, 1:10000, Paris, France). Signals from immunopositive bands were visualized on X-ray film using alkaline phosphatase-linked secondary antibody (Applied Biosystems, T2191 or T2192, 1:20000) and an enhanced chemiluminescence system CDP-Star (Applied Biosystems). Quantifications were carried out with ImageJ freeware (http:// rsb.info.nih.gov/ij/) after scanning of the different blots.
Immunofluorescence Different antibodies were used: mAb anti-HEF1 (clone 2G9, ImmuQuest), mAb anti-vinculin (clone hVIN-1, Sigma) and mAb anti-E-cadherin (clone 36, BD Transduction Laboratories, San Jose, CA USA). HepG2 cells were seeded on glass coverslips 72 h before being processed for immunofluorescence (B5 Â 10 5 cells per well in 6-well plates). Treatments with TCDD (25 nM) were carried out for 48 h in DMEM without phenol red and supplemented with 3% charcoal-treated calf serum. For immunofluorescence, all steps were carried out at room temperature. The coverslips were washed twice in 1 Â PBS and then fixed with 4% paraformadehyde for 10 min. The cells were permeabilized for 10 min in 0.5% PBS-Triton and incubated in 1% PBS-BSA for 10 min. The primary antibody incubations were carried out for 1 h at room temperature at a dilution of 1:50 (HEF1), 1:400 (vinculin) and 1:100 (Ecadherin) in 1% PBS-BSA. Secondary antibody (Alexa Fluor 488 dye-conjugated anti-mouse antibody, Invitrogen SARL, Cergy-Pontoise, France) was diluted in 1% PBS-BSA and incubated with the slides for 1 h at room temperature. For actin staining, TRITC-conjugated phalloidin was included during incubation with the secondary antibody. The coverslips were sealed by Vectashield mounting medium (Abcys, Paris, France) for fluorescence with 4,6-diamidino-2-phenylindole (Vector Laboratories, Inc, Burlingame, CA, USA) and images were acquired using Nikon Eclipse TE-2000 E microscopy. Deconvolution and 3D reconstitution was applied using Autoquant imaging Autodeblur version X 1.4.1 (AutoDebur & Autovisualize, Mediacybernetics, Bethesda, MD, USA).
Matrigel invasion assay
Cell invasion was measured using matrigel-coated film insert (8-mm pore size) fitting into 24-well invasion chambers (Beckon-Dickinson Bioscience, Franklin Lakes, NJ, USA). HepG2 cells (5 Â 10 4 ), which were resuspended in 500 ml DMEM without phenol red and supplemented with 1% BSA, were added to the upper compartment of the invasion chamber in presence or absence of 25 nM TCDD. Medium containing 10% FBS in presence or absence of 25 nM TCDD was placed in the lower compartment of the invasion chamber to act as a chemoattractant. After 48-h incubation at 37 1C in a 5% CO 2 incubator, the non-invading cells on the upper surface of the filter was wiped off using cotton swabs. Cells that invaded through the filters were fixed, stained with crystal violet and counted under the microscope by selecting four fields per filter ( Â 20 magnification). Values obtained were calculated by averaging the total number (four fields of each triplicate filter).
Statistical analysis
All the data are representative of at least three different experiments. Values are expressed as mean±s.e.m. Statistical analysis was carried out using successively the Mann-Whitney's U-test (nonparametric comparison of two independent series) or H Kruskal-Wallis test (nonparametric comparison of k independent series) followed by a one-factor analysis of variance test (parametric comparison of k independent series).
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